Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
BBLG
Valuation N/A
Bone Biologics Corp
Price$0.47
Model IV—
P/IV—
Limited data — see page
BBLGW
Valuation N/A
Bone Biologics Corp
Price$7.70
Model IV—
P/IV—
Limited data — see page
BBN
Valuation N/A
BlackRock Taxable Municipal Bond Trust
Price$14.43
Model IV—
P/IV—
Limited data — see page
BCAB
Valuation N/A
BioAtla, Inc.
Price$1.50
Model IV—
P/IV—
Market implies +78.1%/yr
BCAC
Valuation N/A
BCAC
Price$4.93
Model IV—
P/IV—
Limited data — see page
BCAR
Valuation N/A
BCAR
Price$0.97
Model IV—
P/IV—
Limited data — see page
BCARU
Valuation N/A
BCARU
Price$5.16
Model IV—
P/IV—
Limited data — see page
BCARW
Valuation N/A
BCARW
Price$0.48
Model IV—
P/IV—
Limited data — see page
BCBP
Deeply undervalued
BCB BANCORP INC
Price$8.23
Model IV$14.39
P/IV0.59
Discount 43%
Return to IV: +74.9%
BCDA
Valuation N/A
BioCardia, Inc.
Price$1.04
Model IV—
P/IV—
Market implies +62.5%/yr
BCG
Deeply undervalued
Binah Capital Group, Inc.
Price$1.05
Model IV$2.83
P/IV0.44
Discount 63%
Return to IV: +169.3%
Market implies -13.7%/yr
vs model +7.3% · below model
BCGWW
Valuation N/A
Binah Capital Group, Inc.
Price$0.04
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +6.3% · below model
BCHT
Deeply overvalued
Birchtech Corp.
Price$1.39
Model IV$0.80
P/IV1.87
Premium +73%
Return to IV: -42.3%
Market implies +5.5%/yr
vs model +7.9% · in line
BCIC
Deeply undervalued
BCP Investment Corp
Price$6.93
Model IV$77.86
P/IV0.09
Discount 91%
Return to IV: +1,023.5%
Market implies -45.6%/yr
vs model +6.0% · below model
BCSS
Valuation N/A
Bain Capital GSS Investment Corp.
Price$10.23
Model IV—
P/IV—
Limited data — see page
BCTX
Valuation N/A
BriaCell Therapeutics Corp.
Price$3.91
Model IV—
P/IV—
Limited data — see page
BCTXL
Valuation N/A
BriaCell Therapeutics Corp.
Price$1.10
Model IV—
P/IV—
Limited data — see page
BCTXZ
Valuation N/A
BriaCell Therapeutics Corp.
Price$0.21
Model IV—
P/IV—
Limited data — see page
BCV
Valuation N/A
BANCROFT FUND LTD
Price$23.21
Model IV—
P/IV—
Limited data — see page
BCYC
Undervalued
BICYCLE THERAPEUTICS PLC
Price$3.89
Model IV$5.11
P/IV0.70
Discount 24%
Return to IV: +31.3%
Market implies -5.3%/yr
vs model +50.0% · below model
BDCI
Valuation N/A
BTC Development Corp.
Price$10.13
Model IV—
P/IV—
Limited data — see page
BDCIU
Valuation N/A
BTC Development Corp.
Price$10.29
Model IV—
P/IV—
Limited data — see page
BDCIW
Valuation N/A
BTC Development Corp.
Price$0.37
Model IV—
P/IV—
Limited data — see page
BDL
Deeply overvalued
FLANIGANS ENTERPRISES INC
Price$46.79
Model IV$30.40
P/IV1.39
Premium +54%
Return to IV: -35.0%
Market implies +10.7%/yr
vs model +8.8% · in line
BDMD
Deeply overvalued
Baird Medical Investment Holdings Ltd
Price$0.77
Model IV$0.17
P/IV4.35
Premium +346%
Return to IV: -77.6%
Market implies +19.9%/yr
vs model +2.0% · above model
BDMDW
Valuation N/A
Baird Medical Investment Holdings Ltd
Price$0.03
Model IV—
P/IV—
Market implies -37.5%/yr
vs model +2.0% · below model
BDSX
Deeply overvalued
BIODESIX INC
Price$26.02
Model IV$10.48
P/IV2.69
Premium +148%
Return to IV: -59.7%
Market implies +10.5%/yr
vs model +12.9% · in line
BDTX
Deeply overvalued
Black Diamond Therapeutics, Inc.
Price$1.83
Model IV$0.77
P/IV2.44
Premium +137%
Return to IV: -57.7%
Market implies +13.1%/yr
vs model +15.0% · in line
BEAG
Valuation N/A
Bold Eagle Acquisition Corp.
Price$10.69
Model IV—
P/IV—
Limited data — see page
BEAGR
Valuation N/A
Bold Eagle Acquisition Corp.
Price$0.23
Model IV—
P/IV—
Limited data — see page
BEAGU
Valuation N/A
Bold Eagle Acquisition Corp.
Price$11.22
Model IV—
P/IV—
Limited data — see page
BEAT
Valuation N/A
HeartBeam, Inc.
Price$0.48
Model IV—
P/IV—
Limited data — see page
BEATW
Valuation N/A
HeartBeam, Inc.
Price$0.01
Model IV—
P/IV—
Limited data — see page
BEBE
Valuation N/A
TGE Value Creative Solutions Corp
Price$10.05
Model IV—
P/IV—
Limited data — see page
BEEM
Valuation N/A
Beam Global
Price$1.07
Model IV—
P/IV—
Market implies +87.1%/yr
BEEP
Deeply overvalued
Mobile Infrastructure Corp
Price$2.73
Model IV$1.10
P/IV2.34
Premium +149%
Return to IV: -59.8%
Market implies +9.6%/yr
vs model +15.0% · below model
BENF
Valuation N/A
Beneficient
Price$1.05
Model IV—
P/IV—
Market implies -1.5%/yr
BENFW
Valuation N/A
Beneficient
Price$0.01
Model IV—
P/IV—
Market implies -30.0%/yr
BESS
Deeply overvalued
Bimergen Energy Corp
Price$2.20
Model IV$0.62
P/IV3.76
Premium +258%
Return to IV: -72.0%
BETR
Valuation N/A
Better Home & Finance Holding Co
Price$9.86
Model IV—
P/IV—
Market implies +17.3%/yr
BETRW
Valuation N/A
Better Home & Finance Holding Co
Price$0.14
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +15.0% · below model
BFRG
Valuation N/A
BullFrog AI Holdings, Inc.
Price$0.65
Model IV—
P/IV—
Market implies +58.6%/yr
BFRGW
Valuation N/A
BullFrog AI Holdings, Inc.
Price$0.14
Model IV—
P/IV—
Market implies +40.6%/yr
vs model +15.0% · above model
BFRI
Deeply undervalued
Biofrontera Inc.
Price$0.97
Model IV$2.78
P/IV0.37
Discount 65%
Return to IV: +186.1%
Market implies -21.5%/yr
vs model +14.7% · below model
BFRIW
Valuation N/A
Biofrontera Inc.
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
BGB
Valuation N/A
Blackstone Strategic Credit 2027 Term Fund
Price$11.12
Model IV—
P/IV—
Limited data — see page
BGDE
Valuation N/A
Big Digital Energy, Inc.
Price$5.13
Model IV—
P/IV—
Market implies -21.1%/yr
BGH
Valuation N/A
BARINGS GLOBAL SHORT DURATION HIGH YIELD FUND
Price$13.05
Model IV—
P/IV—
Limited data — see page
BGI
Valuation N/A
BGI
Price$0.22
Model IV—
P/IV—
Limited data — see page
BGIN
Valuation N/A
BGIN BLOCKCHAIN Ltd
Price$2.10
Model IV—
P/IV—
Market implies +40.7%/yr
BGL
Deeply overvalued
Blue Gold Ltd
Price$0.17
Model IV$0.07
P/IV3.36
Premium +152%
Return to IV: -60.3%
Market implies +15.6%/yr
vs model +5.0% · above model
BGLC
Deeply overvalued
BioNexus Gene Lab Corp
Price$1.29
Model IV$0.53
P/IV2.74
Premium +142%
Return to IV: -58.7%
Market implies +10.7%/yr
vs model +2.0% · above model
BGLWW
Deeply undervalued
Blue Gold Ltd
Price$0.03
Model IV$0.07
P/IV0.44
Discount 61%
Return to IV: +158.6%
Market implies -25.0%/yr
vs model +5.0% · below model
BGMS
Valuation N/A
Bio Green Med Solution, Inc.
Price$0.85
Model IV—
P/IV—
Market implies +52.6%/yr
BGS
Deeply undervalued
B&G Foods, Inc.
Price$2.40
Model IV$7.03
P/IV0.43
Discount 66%
Return to IV: +192.9%
Market implies -17.9%/yr
vs model +2.0% · below model
BGSF
Deeply undervalued
BGSF, INC.
Price$4.75
Model IV$8.07
P/IV0.61
Discount 41%
Return to IV: +69.8%
Market implies -8.2%/yr
vs model +2.0% · below model
BGT
Valuation N/A
BLACKROCK FLOATING RATE INCOME TRUST
Price$10.38
Model IV—
P/IV—
Limited data — see page
BGX
Valuation N/A
Blackstone Long-Short Credit Income Fund
Price$10.55
Model IV—
P/IV—
Limited data — see page
BGY
Valuation N/A
BlackRock Enhanced International Dividend Trust
Price$5.73
Model IV—
P/IV—
Limited data — see page
BHAV
Valuation N/A
BHAV Acquisition Corp
Price$10.03
Model IV—
P/IV—
Limited data — see page
